Risch H - Search Results

1

IGF-I in epithelial ovarian cancer and its role in disease progression.

Brokaw J, Katsaros D, Wiley A, Lu L, Su D, Sochirca O, de la Longrais IA, Mayne S, Risch H, Yu H. Brokaw J, et al. Among authors: risch h. Growth Factors. 2007 Oct;25(5):346-54. doi: 10.1080/08977190701838402. Growth Factors. 2007. PMID: 18236213

2

Pelvic inflammatory disease and the risk of epithelial ovarian cancer.

Risch HA, Howe GR. Risch HA, et al. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):447-51. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7549798

3

Dietary fat intake and risk of epithelial ovarian cancer.

Risch HA, Jain M, Marrett LD, Howe GR. Risch HA, et al. J Natl Cancer Inst. 1994 Sep 21;86(18):1409-15. doi: 10.1093/jnci/86.18.1409. J Natl Cancer Inst. 1994. PMID: 8072035

4

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.

Risch HA, Marrett LD, Jain M, Howe GR. Risch HA, et al. Am J Epidemiol. 1996 Aug 15;144(4):363-72. doi: 10.1093/oxfordjournals.aje.a008937. Am J Epidemiol. 1996. PMID: 8712193

5

Estrogen replacement therapy and risk of epithelial ovarian cancer.

Risch HA. Risch HA. Gynecol Oncol. 1996 Nov;63(2):254-7. doi: 10.1006/gyno.1996.0315. Gynecol Oncol. 1996. PMID: 8910636 Free article.

6

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.

Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF Jr. Gammon MD, et al. Among authors: risch ha. J Natl Cancer Inst. 1997 Sep 3;89(17):1277-84. doi: 10.1093/jnci/89.17.1277. J Natl Cancer Inst. 1997. PMID: 9293918

7

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.

Risch HA. Risch HA. J Natl Cancer Inst. 1998 Dec 2;90(23):1774-86. doi: 10.1093/jnci/90.23.1774. J Natl Cancer Inst. 1998. PMID: 9839517 Review.

8

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.

Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow WH, Risch HA, Stanford JL, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West AB, Dubrow R, Fraumeni JF Jr, Blot WJ. Farrow DC, et al. Among authors: risch ha. Cancer Causes Control. 2000 Mar;11(3):231-8. doi: 10.1023/a:1008913828105. Cancer Causes Control. 2000. PMID: 10782657

9

Family history of cancer and risk of esophageal and gastric cancers in the United States.

Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr. Dhillon PK, et al. Among authors: risch ha. Int J Cancer. 2001 Jul 1;93(1):148-52. doi: 10.1002/ijc.1294. Int J Cancer. 2001. PMID: 11391635 Free article.

10

Nutrient intake and risk of subtypes of esophageal and gastric cancer.

Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Farrow DC, Schoenberg JB, Stanford JL, Ahsan H, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr. Mayne ST, et al. Among authors: risch ha. Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1055-62. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11588131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page